尼日利亚心力衰竭:系统审查和元分析的协议
Okechukwu S Ogah1,2,3, Oyewole A Kushimo4, Adewole Adebiyi1,2
1Cardiology Unit, Department of Medicine, University of Ibadan, Ibadan, Oyo State, Nigeria.
African health sciences
|January 15, 2024
概括
本系统性审查审查了尼日利亚心力衰竭,这是一个日益增长的非传染性疾病负担. 它的目的是建立更好的公共卫生指导的流行率,风险因素和管理策略.
科学领域:
- 心脏病学 心脏病学
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 心力衰竭在尼日利亚是一个重大挑战,尼日利亚是一个正在经历流行病学和人口结构变化的国家.
- 尼日利亚目前对心力衰竭流行病学的了解有限.
- 包括心力衰竭在内的非传染性疾病在发展中国家越来越普遍.
研究的目的:
- 系统地审查和对尼日利亚心力衰竭的流行情况进行元分析.
- 在尼日利亚背景下确定心力衰竭的主要病因,危险因素和管理策略.
- 为未来的研究和政策干预提供基于证据的指导.
主要方法:
- 在多个数据库 (PubMed/Medline,EMBASE,科学网,谷歌学者,非洲指数医学,非洲杂志在线) 中进行了全面的搜索.
- 包括2000年1月至2021年12月以英语出版的观察性研究,重点关注12岁及以上的尼日利亚成年人.
- 独立审稿人进行了文章选择和数据提取,以确保严格的方法.
主要成果:
- 主要结果是尼日利亚心力衰竭的综合患病率.
- 二次结局包括识别与心力衰竭相关的流行风险因素.
- 分析还将重点关注国内心力衰竭的当前管理方法.
结论:
- 这项研究是首次对尼日利亚心力衰竭流行病学进行系统性审查和元分析.
- 结果将突出研究差距,并为心力衰竭管理的政策制定提供信息.
- 该审查旨在改善尼日利亚对心力衰竭的理解和结果.
相关概念视频
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
432
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
432
01:22Heart Failure Drugs: β-Blockers
341
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
341
01:22Heart Failure Drugs: Diuretics
384
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
384
01:26Heart Failure Drugs: Inotropic Agents
591
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
591
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
93
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
93